Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
1989-8-23
|
pubmed:abstractText |
20(S)-Camptothecin, the 20(S)-camptothecin sodium salt, and 12 analogues with substituents on the A ring differ widely in their effectiveness in the treatment of murine L1210 lymphoblastic leukemia in vivo. The drugs were screened in the following systems: System 1, the cleavage of DNA in the presence of purified topoisomerase I; System 2, drug-induced trapping of topoisomerase I in a covalent complex with DNA; and System 3, the induction of protein-associated DNA breaks in drug-treated L1210 leukemia cells. 9-Amino-20(S), 10-amino-20(RS), and 10,11-methylenedioxy-20(RS), drugs effective against murine L1210 leukemia in vivo, stabilize topoisomerase I-DNA cleavable complexes in a purified system and in cultured L1210 cells. Other analogues, inactive against L1210 leukemia in vivo, were totally ineffective in topoisomerase I-directed screens. The rest of the analogues were intermediate in terms of their antitumor and topoisomerase I-directed activities. The study shows that the drug-induced accumulation of enzyme-DNA cleavable complexes is directly proportional to drug cytotoxicity and antitumor activity.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4385-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2545341-Animals,
pubmed-meshheading:2545341-Camptothecin,
pubmed-meshheading:2545341-Cell Survival,
pubmed-meshheading:2545341-DNA, Circular,
pubmed-meshheading:2545341-DNA, Neoplasm,
pubmed-meshheading:2545341-DNA Damage,
pubmed-meshheading:2545341-DNA Topoisomerases, Type I,
pubmed-meshheading:2545341-Dose-Response Relationship, Drug,
pubmed-meshheading:2545341-Leukemia L1210,
pubmed-meshheading:2545341-Mice,
pubmed-meshheading:2545341-Mice, Inbred BALB C,
pubmed-meshheading:2545341-Mice, Inbred DBA,
pubmed-meshheading:2545341-Structure-Activity Relationship
|
pubmed:year |
1989
|
pubmed:articleTitle |
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
|
pubmed:affiliation |
Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|